Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Aberrant BAF57 signaling facilitates prometastatic phenotypes.

Balasubramaniam S, Comstock CE, Ertel A, Jeong KW, Stallcup MR, Addya S, McCue PA, Ostrander WF Jr, Augello MA, Knudsen KE.

Clin Cancer Res. 2013 May 15;19(10):2657-67. doi: 10.1158/1078-0432.CCR-12-3049. Epub 2013 Mar 14.

2.

Targeting the BAF57 SWI/SNF subunit in prostate cancer: a novel platform to control androgen receptor activity.

Link KA, Balasubramaniam S, Sharma A, Comstock CE, Godoy-Tundidor S, Powers N, Cao KH, Haelens A, Claessens F, Revelo MP, Knudsen KE.

Cancer Res. 2008 Jun 15;68(12):4551-8. doi: 10.1158/0008-5472.CAN-07-6392.

3.

BAF57 governs androgen receptor action and androgen-dependent proliferation through SWI/SNF.

Link KA, Burd CJ, Williams E, Marshall T, Rosson G, Henry E, Weissman B, Knudsen KE.

Mol Cell Biol. 2005 Mar;25(6):2200-15.

4.

Identification and characterization of novel potentially oncogenic mutations in the human BAF57 gene in a breast cancer patient.

Villaronga MA, López-Mateo I, Markert L, Espinosa E, Fresno Vara JA, Belandia B.

Breast Cancer Res Treat. 2011 Aug;128(3):891-8. doi: 10.1007/s10549-011-1492-4. Epub 2011 Apr 5.

PMID:
21465167
5.

The BRG1- and hBRM-associated factor BAF57 induces apoptosis by stimulating expression of the cylindromatosis tumor suppressor gene.

Wang L, Baiocchi RA, Pal S, Mosialos G, Caligiuri M, Sif S.

Mol Cell Biol. 2005 Sep;25(18):7953-65.

6.

A role for BAF57 in cell cycle-dependent transcriptional regulation by the SWI/SNF chromatin remodeling complex.

Hah N, Kolkman A, Ruhl DD, Pijnappel WW, Heck AJ, Timmers HT, Kraus WL.

Cancer Res. 2010 Jun 1;70(11):4402-11. doi: 10.1158/0008-5472.CAN-09-2767. Epub 2010 May 11.

7.

Identification of BAF57 mutations in human breast cancer cell lines.

Kiskinis E, García-Pedrero JM, Villaronga MA, Parker MG, Belandia B.

Breast Cancer Res Treat. 2006 Jul;98(2):191-8. Epub 2006 Mar 15.

PMID:
16538531
8.

Sox2 is an androgen receptor-repressed gene that promotes castration-resistant prostate cancer.

Kregel S, Kiriluk KJ, Rosen AM, Cai Y, Reyes EE, Otto KB, Tom W, Paner GP, Szmulewitz RZ, Vander Griend DJ.

PLoS One. 2013;8(1):e53701. doi: 10.1371/journal.pone.0053701. Epub 2013 Jan 11.

9.

The SWI/SNF chromatin remodeling subunit BAF57 is a critical regulator of estrogen receptor function in breast cancer cells.

García-Pedrero JM, Kiskinis E, Parker MG, Belandia B.

J Biol Chem. 2006 Aug 11;281(32):22656-64. Epub 2006 Jun 12.

10.

hZimp7, a novel PIAS-like protein, enhances androgen receptor-mediated transcription and interacts with SWI/SNF-like BAF complexes.

Huang CY, Beliakoff J, Li X, Lee J, Li X, Sharma M, Lim B, Sun Z.

Mol Endocrinol. 2005 Dec;19(12):2915-29. Epub 2005 Jul 28.

PMID:
16051670
11.

Androgen receptor-independent function of FoxA1 in prostate cancer metastasis.

Jin HJ, Zhao JC, Ogden I, Bergan RC, Yu J.

Cancer Res. 2013 Jun 15;73(12):3725-36. doi: 10.1158/0008-5472.CAN-12-3468. Epub 2013 Mar 28.

12.

ERG is a critical regulator of Wnt/LEF1 signaling in prostate cancer.

Wu L, Zhao JC, Kim J, Jin HJ, Wang CY, Yu J.

Cancer Res. 2013 Oct 1;73(19):6068-79. doi: 10.1158/0008-5472.CAN-13-0882. Epub 2013 Aug 1.

13.

Flightless I Homolog Represses Prostate Cancer Progression through Targeting Androgen Receptor Signaling.

Wang T, Song W, Chen Y, Chen R, Liu Z, Wu L, Li M, Yang J, Wang L, Liu J, Ye Z, Wang C, Chen K.

Clin Cancer Res. 2016 Mar 15;22(6):1531-44. doi: 10.1158/1078-0432.CCR-15-1632. Epub 2015 Nov 2.

14.

HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes.

Axlund SD, Lambert JR, Nordeen SK.

Mol Cancer Res. 2010 Dec;8(12):1643-55. doi: 10.1158/1541-7786.MCR-10-0111. Epub 2010 Nov 2.

16.

Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers.

Sun A, Tawfik O, Gayed B, Thrasher JB, Hoestje S, Li C, Li B.

Prostate. 2007 Feb 1;67(2):203-13.

PMID:
17075831
17.

Modulation of androgen receptor signaling in hormonal therapy-resistant prostate cancer cell lines.

Marques RB, Dits NF, Erkens-Schulze S, van Ijcken WF, van Weerden WM, Jenster G.

PLoS One. 2011;6(8):e23144. doi: 10.1371/journal.pone.0023144. Epub 2011 Aug 4.

18.

Integration of cap analysis of gene expression and chromatin immunoprecipitation analysis on array reveals genome-wide androgen receptor signaling in prostate cancer cells.

Takayama K, Tsutsumi S, Katayama S, Okayama T, Horie-Inoue K, Ikeda K, Urano T, Kawazu C, Hasegawa A, Ikeo K, Gojyobori T, Ouchi Y, Hayashizaki Y, Aburatani H, Inoue S.

Oncogene. 2011 Feb 3;30(5):619-30. doi: 10.1038/onc.2010.436. Epub 2010 Oct 4.

PMID:
20890304
19.

N-terminally truncated BAF57 isoforms contribute to the diversity of SWI/SNF complexes in neurons.

Kazantseva A, Sepp M, Kazantseva J, Sadam H, Pruunsild P, Timmusk T, Neuman T, Palm K.

J Neurochem. 2009 May;109(3):807-18. doi: 10.1111/j.1471-4159.2009.06005.x. Epub 2009 Feb 20.

Supplemental Content

Support Center